Participants in trials lost an average of 12.4% of their body weight
If these results hold in phase 3 trials, retatrutide may be substantially faster than semaglutide in producing comparable or greater weight loss
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
Indeed, GHRH treatment of these children accelerates growth (6, 15), suggesting that GHRH is an ideal and more physiological treatment when GHD is due to hypothalamic dysfunction rather than to primary pituitary disease
And there are some worries about side-effects (nausea, diarrhoea, vomiting, and constipation), and safety concerns (as with any new drug) which need to be dealt with before it becomes certified for use
Your provider will advise you at your appointment